Literature DB >> 9505825

HLA expression in a primary uveal melanoma, its cell line, and four of its metastases.

D J Blom1, L R Schurmans, I De Waard-Siebinga, D De Wolff-Rouendaal, J E Keunen, M J Jager.   

Abstract

BACKGROUND: The level of HLA expression on a tumour may influence the immunological response against this tumour, and vice versa. HLA expression was determined in a primary uveal melanoma, its metastases, and on a cell line derived from this melanoma, and the presence and type of infiltrate in tissue sections were also studied.
METHODS: Immunohistochemistry with monoclonal antibodies (MAbs) against HLA class I and II, T cells, NK cells, and macrophages.
RESULTS: Primary and metastatic lesions, as well as the cell line showed high levels of expression of the monomorphic determinants of HLA class I. Expression of the polymorphic HLA-A2 and HLA-A3 antigens was decreased on metastases to the skin and liver. HLA-Bw4 expression was low on all lesions, as well as expression of HLA class II. Tumour infiltrating cells consisted mainly of CD3, CD4, and CD8 positive cells. Expression on the cell line corresponded to expression on the primary tumour.
CONCLUSION: The primary uveal melanoma as well as the cell line showed a high expression of monomorphic and polymorphic HLA-A antigens, while metastases showed a high expression of monomorphic and a lower expression of polymorphic antigens. This variation in expression may support tumour cell escape from NK cells as well as CTL mediated lysis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9505825      PMCID: PMC1722057          DOI: 10.1136/bjo.81.11.989

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  17 in total

Review 1.  Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance.

Authors:  S Ferrone; F M Marincola
Journal:  Immunol Today       Date:  1995-10

2.  Inhibition of selective signaling events in natural killer cells recognizing major histocompatibility complex class I.

Authors:  D S Kaufman; R A Schoon; M J Robertson; P J Leibson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

3.  Immunohistochemistry of infiltrating lymphocytes in uveal malignant melanoma.

Authors:  J C Whelchel; S E Farah; I W McLean; M N Burnier
Journal:  Invest Ophthalmol Vis Sci       Date:  1993-07       Impact factor: 4.799

Review 4.  Natural history of HLA expression during tumour development.

Authors:  F Garrido; T Cabrera; A Concha; S Glew; F Ruiz-Cabello; P L Stern
Journal:  Immunol Today       Date:  1993-10

5.  Expression of HLA antigens in paraffin sections of uveal melanomas.

Authors:  M J Jager; D de Wolff-Rouendaal; A C Breebaart; D J Ruiter
Journal:  Doc Ophthalmol       Date:  1986-12-30       Impact factor: 2.379

Review 6.  MHC antigens in human melanomas.

Authors:  D J Ruiter; V Mattijssen; E B Broecker; S Ferrone
Journal:  Semin Cancer Biol       Date:  1991-02       Impact factor: 15.707

7.  Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer.

Authors:  A Concha; F Esteban; T Cabrera; F Ruiz-Cabello; F Garrido
Journal:  Semin Cancer Biol       Date:  1991-02       Impact factor: 15.707

8.  Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model.

Authors:  D Ma; G P Luyten; T M Luider; J Y Niederkorn
Journal:  Invest Ophthalmol Vis Sci       Date:  1995-02       Impact factor: 4.799

9.  Establishment and characterization of an uveal-melanoma cell line.

Authors:  I De Waard-Siebinga; D J Blom; M Griffioen; P I Schrier; E Hoogendoorn; G Beverstock; E H Danen; M J Jager
Journal:  Int J Cancer       Date:  1995-07-17       Impact factor: 7.396

10.  Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule.

Authors:  L L Lanier; R Testi; J Bindl; J H Phillips
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

View more
  13 in total

1.  Defective FasL expression is associated with increased resistance to melanoma liver metastases and enhanced natural killer cell activity.

Authors:  Sudha Neelam; Jessamee Mellon; Amber Wilkerson; Jerry Y Niederkorn
Journal:  Melanoma Res       Date:  2019-08       Impact factor: 3.599

Review 2.  Immune escape mechanisms of intraocular tumors.

Authors:  Jerry Y Niederkorn
Journal:  Prog Retin Eye Res       Date:  2009-06-27       Impact factor: 21.198

Review 3.  Uveal Melanoma Cell Lines: Where do they come from? (An American Ophthalmological Society Thesis).

Authors:  Martine J Jager; J Antonio Bermudez Magner; Bruce R Ksander; Sander R Dubovy
Journal:  Trans Am Ophthalmol Soc       Date:  2016-08

4.  The relation between c-myc expression and interferon sensitivity in uveal melanoma.

Authors:  P N Tulley; M Neale; D Jackson; J S Chana; R Grover; I Cree; A O Grobbelaar; G D Wilson
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638

5.  Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2.

Authors:  J C Becker; P Terheyden; E Kämpgen; S Wagner; C Neumann; D Schadendorf; A Steinmann; G Wittenberg; W Lieb; E-B Bröcker
Journal:  Br J Cancer       Date:  2002-10-07       Impact factor: 7.640

6.  Upregulation of HLA Expression in Primary Uveal Melanoma by Infiltrating Leukocytes.

Authors:  T Huibertus van Essen; Sake I van Pelt; Inge H G Bronkhorst; Mieke Versluis; Fariba Némati; Cécile Laurent; Gregorius P M Luyten; Thorbald van Hall; Peter J van den Elsen; Pieter A van der Velden; Didier Decaudin; Martine J Jager
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

7.  Loss of nonclassical MHC molecules MIC-A/B expression during progression of uveal melanoma.

Authors:  C S Vetter; W Lieb; E-B Bröcker; J C Becker
Journal:  Br J Cancer       Date:  2004-10-18       Impact factor: 7.640

8.  Growth and Metastasis of Intraocular Tumors in Aged Mice.

Authors:  Zhiqiang Han; Joseph R Brown; Jerry Y Niederkorn
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-05-01       Impact factor: 4.799

9.  Natural Killer T Cells Contribute to Neutrophil Recruitment and Ocular Tissue Damage in a Model of Intraocular Tumor Rejection.

Authors:  Ann J Ligocki; Jerry Y Niederkorn
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-03       Impact factor: 4.799

10.  ICG-001 Exerts Potent Anticancer Activity Against Uveal Melanoma Cells.

Authors:  Salma Kaochar; Jianrong Dong; Marie Torres; Kimal Rajapakshe; Fotis Nikolos; Christel M Davis; Erik A Ehli; Cristian Coarfa; Nicholas Mitsiades; Vasiliki Poulaki
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-01-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.